Register
Register
Register

Wednesday, 2 December 2026 | 11:45 - 12:45

Parallel session: How can EU coordination help scale up advanced therapies?

This session looks at the latest EU policy initiatives, including the European Life Sciences Strategy, the proposed Biotech Act and the Competitiveness Coordination Tool, and what they mean for the advanced therapy medicinal products (ATMPs) sector. This roundtable brings together industry, investors and national governments to discuss how we can work together to strengthen Europe’s competitiveness in ATMPs, supporting their development, manufacturing and patient access. 

Moderator: Maria Pilar Aguar Fernandez, Director People, DG Research and Innovation, European Commission 

Speakers/Panel: 

  • Heinz JANSEN, Head of the EU's future Competitiveness Task Force, Secretariat General, European Commission 

  • Arno de Wilde, Managing Director Life Sciences, EQT, Netherlands 

  • Lydia Shotton, Associate Director for Government Affairs, Alliance for Regenerative Medicine, Belgium

  • Daniel Naumovas, Vice-Minister at the Ministry of Health of the Republic of Lithuania